A whole new view of CB2
|
NIDA-funded scientists have recently identified the crystal structure of the CB1 receptor and have some understanding of how it modulates the system.
News Releases
Scientists closer to finding inherited traits in addiction
|
Scientists have concluded that the risk of addiction is a complex combination of both genes and environmental influences.
Teens using vaping devices in record numbers
|
America’s teens report a dramatic increase in their use of vaping devices in just a single year, with 37.3 percent of 12th graders reporting “any vaping” in the past 12...
National Institute on Drug Abuse to hold teleconference discussing key findings of 2018 Monitoring the Future Survey on teen drug use
|
The National Institute on Drug Abuse (NIDA) will hold a teleconference on Monday, December 17, to discuss the results of the 2018 Monitoring the Future (MTF) survey.
ABCD study completes enrollment, announces opportunities for scientific engagement
|
The National Institutes of Health announced today that enrollment for the Adolescent Brain Cognitive Development (ABCD) Study is now complete and, in early 2019, scientists will have access to baseline...
NIDA-NIAAA 2018 Mini-Convention: Frontiers in Addiction Research
|
The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), both part of the National Institutes of Health, will host a one-day mini...
Study shows impact of social interactions on addictive behavior
|
A new study published in Nature Neuroscience finds that social interactions can have a profound effect on behaviors related to addiction, and on the brain’s response to drug-associated cues.
New opioid treatment resources for emergency department clinicians
|
The National Institute on Drug Abuse (NIDA) today announced the availability of informational resources for clinicians interested in initiating buprenorphine treatment in emergency department settings.
Daily use of marijuana among non-college young adults at all time high
|
The National Institute on Drug Abuse (NIDA) announced that the latest Monitoring the Future (MTF) survey results on substance use trends as teens transition to adulthood are now available online...
Journal commentary addresses role of dentists in opioid crisis
|
The commentary, authored by Dr. Nora Volkow, director of the National Institute on Drug Abuse, and Dr. Martha Somerman, director of the National Institute of Dental and Craniofacial Research, both...
Study casts doubt on effectiveness of e-cigs for smoking cessation
|
A study found no evidence that smokers who used e-cigarettes and other electronic nicotine delivery systems (ENDS) in the United States were more likely to quit smoking cigarettes than smokers...
2018 Avenir award recipient to study how social networks affect people who use drugs
|
A proposal to study how drug users who are part of social networks influence their own communities has been given the 2018 Avenir award for HIV/AIDS research by the National...
New clinician screening tool available for substance use
|
The National Institute on Drug Abuse (NIDA) Clinical Trials Network has unveiled a new scientifically validated, online screening tool designed to assess a patient’s risk for substance misuse and substance...
Training module now available for acute pain management in hospitalized adults
|
A case-based clinician training module designed for the evaluation of acute pain and opioid management for adults is now available through the Centers of Excellence in Pain Education (CoEPE) program...
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications
|
A comprehensive analysis of health insurance coverage of non-opioid and opioid medications to treat chronic low back pain concluded that some insurance plans have missed important opportunities to steer patients...
Methadone and buprenorphine reduce risk of death after opioid overdose
|
A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid...
Special journal issue highlights ABCD brain study
|
The special issue is an overview of the ABCD Study and includes articles about the rationale for the study, its design and recruitment strategy, assessment protocols and neuroimaging parameters, the...
Full survey of annual teen drug use now available with additional data
|
The complete volume of the 2017 Monitoring the Future Survey (MTF) teen drug use and behavior survey results is now available online with never before seen highlights about drug use...
Higher rate of substance use among Native American youth on reservations
|
A survey comparing drug use among Native American youth living on or near reservations to a national sample of American youth found that Native American youth report substantially higher use...
Method to identify undetected drug suicides wins top NIDA Addiction Science Award
|
A project that identified and tested a bioinformatics program that can help identify underreported suicides linked to drug overdoses was awarded the first-place distinction at the 2018 Intel International Science...
FDA approves first medication to reduce opioid withdrawal symptoms
|
Lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S. Food and Drug Administration.
Study upends conventional view of opioid mechanism of action
|
A new discovery shows that opioids used to treat pain, such as morphine and oxycodone, produce their effects by binding to receptors inside neurons, contrary to conventional wisdom that they...
Nearly half of opioid-related overdose deaths involve fentanyl
|
An analysis of opioid-related overdose deaths found that synthetic opioids, such as illicit fentanyl, have surpassed prescription opioids as the most common drug involved in overdose deaths in the U.S.
Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division
|
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, welcomed Dr. Kurt Rasmussen today as the Director of the Division of Therapeutics and Medical...
Understanding the Neuroscience of Addiction: what it means for prevention and treatment
|
Advances in the understanding of brain development, as well as the role that genes and environment play in addiction, are the focus of a review article published today in The...
Five million American adults misusing prescription stimulants
|
Looking at annual averages, approximately 6.6% (or 16 million) of U.S. adults used prescription stimulants in the preceding year; 4.5% (or 11 million) used prescription stimulants appropriately (without misuse); 2.1%...
Study changes long-held concepts of cell decoding
|
Scientists at the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) have uncovered evidence that shows a more complex and elaborate role for the body's hard-working G protein-coupled...
Non-psychoactive cannabinoid may enable drug addiction recovery
|
Cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may help reduce the risk of drug and alcohol relapse.
E-cigarette ads associated with cigarette smoking initiation among youth
|
A scientific study finds that receptivity to e-cigarette advertising increases the likelihood of trying conventional cigarettes one year later.
NIDA's 2018 Avant-Garde awards highlight immune response and killer cells
|
NIDA’s annual Avant-Garde Award competition, now in its 11th year, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in...